Please Wait.....
Report
Europe Syndromic Multiplex Diagnostic Market
Market Report I 2025-04-01 I 350 Pages I Data Bridge Market Research
The Europe syndromic multiplex diagnostic market is expected to reach USD 2.19 billion by 2032 from USD 1.17 billion in 2024, growing at a CAGR of 8.2% in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Syndromic Multiplex Diagnostic Market, By Product Type (Accessories & Consumables, Instruments, and Software & Services), Infection Type (Viral, Bacterial, Fungal, Parasites, and Others), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Meningitis, Childhood Infections, Immunosuppression, Tropical Fever, Hepatitis, Eye Infections, and Other Diseases), End User (Hospitals, Clinical Laboratories, Physician Offices, Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Sweden, Poland, Denmark, Norway, Finland, and Rest of Europe) - Industry Trends & Forecast To 2032
Overview of the Europe Syndromic Multiplex Diagnostic Market Dynamics:
Drivers
- Rising prevalence of infectious diseases
- Rising adoption of molecular diagnostics techniques
Restraints
- High cost of diagnostic products
- Variability in test performance across different manufacturers
Opportunities
- Advancements in AI & automation
- Rising aging population in Europe
Market Players:
The key market players for Europe Syndromic Multiplex Diagnostic Market are listed below:
- F. Hoffmann-La Roche Ltd
- DiaSorin S.p.A
- BIOMERIEUX
- Thermo Fisher Scientific Inc.
- QIAGEN
- BD Veritor (BD)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Seegene Inc.
- Hologic, Inc. (U.S.)
- Bosch Healthcare Solutions GmbH
- Abbott
- QuidelOrtho Corporation
- Biocartis
- PathoFinder
TABLE OF CONTENTS
1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.3 OVERVIEW OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET 34
1.4 LIMITATIONS 36
1.5 MARKETS COVERED 36
2 MARKET SEGMENTATION 39
2.1 MARKETS COVERED 39
2.2 GEOGRAPHICAL SCOPE 40
2.3 YEARS CONSIDERED FOR THE STUDY 40
2.4 CURRENCY AND PRICING 40
2.5 DBMR TRIPOD DATA VALIDATION MODEL 41
2.6 MULTIVARIATE MODELLING 44
2.7 PRODUCT TYPE LIFELINE CURVE 44
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 45
2.9 DBMR MARKET POSITION GRID 46
2.10 MARKET END USER COVERAGE GRID 47
2.11 VENDOR SHARE ANALYSIS 48
2.12 SECONDARY SOURCES 49
2.13 ASSUMPTIONS 49
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 55
4.1 PESTAL ANALYSIS 56
4.2 PORTERS FIVE FORCES ANALYSIS 57
4.3 INDUSTRY INSIGHTS 58
4.4 TECHNOLOGY ROADMAP 64
5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: REGULATIONS 67
6 MARKET OVERVIEW 70
6.1 DRIVERS 72
6.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES 72
6.1.2 RISING ADOPTION OF MOLECULAR DIAGNOSTICS TECHNIQUES 73
6.1.3 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS 74
6.1.4 INCREASING DEMAND FOR FAST AND ACCURATE DIAGNOSTIC RESULTS 75
?
6.2 RESTRAINTS 76
6.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS 76
6.2.2 VARIABILITY IN TEST PERFORMANCE ACROSS DIFFERENT MANUFACTURERS 76
6.3 OPPORTUNITIES 77
6.3.1 ADVANCEMENTS IN AI & AUTOMATION 77
6.3.2 RISING AGING POPULATION IN EUROPE 78
6.3.3 RISING HOSPITAL-ACQUIRED INFECTIONS 79
6.4 CHALLENGES 80
6.4.1 CHALLENGES IN DETECTING RESISTANCE MECHANISMS 80
6.4.2 LACK OF MEDICAL PROFESSIONALS IN EUROPE 81
7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE 83
7.1 OVERVIEW 84
7.2 ACCESSORIES & CONSUMABLES 87
7.2.1 PANELS 88
7.2.1.1 MULTIPLEX RESPIRATORY PANELS 89
7.2.1.1.1 MULTIPLEX LOWER RESPIRATORY PANELS 90
7.2.1.1.2 PNEUMONIA (PN)/PNEUMONIA PLUS (PNPLUS) PANELS 91
7.2.1.1.3 UNYVERO LRT TEST 91
7.2.1.1.4 OTHER 91
7.2.1.2 MULTIPLEX UPPER RESPIRATORY PANELS 91
7.2.1.2.1 RESPIRATORY VIRAL PANEL 93
7.2.1.2.2 RESPIRATORY PATHOGEN PANEL (RPP)/RESPIRATORY PANEL 2 (RP2) 93
7.2.1.2.3 RESPIRATORY PANEL EZ (CLIA-WAIVED) 93
7.2.1.2.4 RESPIRATORY PATHOGENS FLEX TEST (RP FLEX) 93
7.2.1.2.5 OTHER PANELS 93
7.2.1.3 MULTIPLEX GI PANELS 93
7.2.1.3.1 GI PATHOGEN PANEL (GPP) 94
7.2.1.3.2 ENTERIC BACTERIAL PANEL 94
7.2.1.3.3 ENTERIC VIRAL PANEL 94
7.2.1.3.4 ENTERIC PARASITE PANEL 94
7.2.1.3.5 EXTENDED ENTERIC BACTERIAL PANEL 94
7.2.1.3.6 OTHER PANELS 94
7.2.1.4 MULTIPLEX BLOOD CULTURE PANELS 95
7.2.1.4.1 BCID PANEL (BROAD-SPECTRUM PATHOGEN IDENTIFICATION) 98
7.2.1.4.2 BCID-GP PANEL (GRAM-POSITIVE BACTERIA PANEL) 98
7.2.1.4.3 BCID-GN PANEL (GRAM-NEGATIVE BACTERIA PANEL) 98
7.2.1.4.4 BCID-FP PANEL (FUNGAL PATHOGEN DETECTION) 98
7.2.1.4.5 GRAM-POSITIVE BLOOD CULTURE TEST (BC-GP) 98
7.2.1.4.6 BLOOD CULTURE TEST (BC-GN) 98
7.2.1.4.7 CANDIDA PANEL 98
7.2.1.4.8 BACTERIA PANEL 98
7.2.1.4.9 PHENOTEST BC 98
7.2.1.4.10 OTHER PANELS 98
7.2.1.5 MENINGITIS/ENCEPHALITIS SYNDROMIC PANEL 98
7.2.1.6 STI TEST PANELS 98
7.2.1.7 OTHER SYNDROMIC MULTIPLEX DIAGNOSTIC PANELS 98
7.3 INSTRUMENTS 99
7.4 SOFTWARE & SERVICES 99
8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE 100
8.1 OVERVIEW 101
8.2 VIRAL 104
8.2.1 RHINOVIRUS 105
8.2.2 CORONAVIRUS 105
8.2.3 ROTAVIRUS 105
8.2.4 ADENOVIRUS 105
8.2.5 OTHERS 105
8.3 BACTERIAL 105
8.3.1 STAPHYLOCOCCUS 105
8.3.2 PNEUMONIA 105
8.3.3 BORDETELLA PERTUSSIS 105
8.3.4 OTHERS 105
8.4 FUNGAL 105
8.5 PARASITES 106
8.6 OTHERS 106
9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE 107
9.1 OVERVIEW 108
9.2 RESPIRATORY INFECTIONS 112
9.3 GASTROENTERITIS 112
9.4 SEXUALLY TRANSMITTED INFECTIONS 112
9.5 MENINGITIS 113
9.6 CHILDHOOD INFECTIONS 113
9.7 IMMUNOSUPPRESSION 113
9.8 TROPICAL FEVER 113
9.9 HEPATITIS 113
9.10 EYE INFECTIONS 113
9.11 OTHER DISEASES 113
10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER 114
10.1 OVERVIEW 115
10.2 HOSPITALS 119
10.2.1 BY TYPE, 119
10.2.1.1 PRIVATE 119
10.2.1.2 PUBLIC 119
10.2.2 BY LEVEL 120
10.2.2.1 TIER 1 120
10.2.2.2 TIER 2 120
10.2.2.3 TIER 3 120
10.3 CLINICAL LABORATORIES 121
10.3.1 BY TYPE 121
10.3.1.1 PRIVATE 121
10.3.1.2 PUBLIC 121
10.4 PHYSICIAN OFFICES 121
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 121
10.6 RESEARCH INSTITUTES 121
10.7 OTHERS 121
11 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL 122
11.1 OVERVIEW 123
11.2 DIRECT TENDER 126
11.3 RETAIL SALES 126
11.3.1 ONLINE 126
11.3.2 OFFLINE 126
11.4 OTHERS 127
12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRIES 128
12.1 EUROPE 128
12.1.1 GERMANY 131
12.1.2 U.K. 142
12.1.3 FRANCE 153
12.1.4 ITALY 164
12.1.5 SPAIN 174
12.1.6 RUSSIA 184
12.1.7 NETHERLANDS 194
12.1.8 TURKEY 213
12.1.9 BELGIUM 223
12.1.10 SWEDEN 233
12.1.11 POLAND 243
12.1.12 DENMARK 253
12.1.13 NORWAY 263
12.1.14 FINLAND 274
12.1.15 REST OF EUROPE 284
13 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY LANDSCAPE 285
13.1 COMPANY SHARE ANALYSIS: EUROPE 285
14 SWOT ANALYSIS 286
15 COMPANY PROFILES 287
15.1 F. HOFFMANN-LA ROCHE LTD 287
15.1.1 COMPANY SNAPSHOT 287
15.1.2 REVENUE ANALYSIS 288
15.1.3 PRODUCT PORTFOLIO 288
15.1.4 RECENT DEVELOPMENTS 289
15.2 DIASORIN S.P.A 290
15.2.1 COMPANY SNAPSHOT 290
15.2.2 REVENUE ANALYSIS 290
15.2.3 SOULUTION PORTFOLIO 291
15.2.4 RECENT DEVELOPMENT 292
15.3 BIOMERIEUX 293
15.3.1 COMPANY SNAPSHOT 293
15.3.2 REVENUE ANALYSIS 293
15.3.3 PRODUCT PORTFOLIO 294
15.3.4 RECENT DEVELOPMENTS/NEWS 295
15.4 THERMO FISHER SCIENTIFIC INC. 297
15.4.1 COMPANY SNAPSHOT 297
15.4.2 REVENUE ANALYSIS 297
15.4.3 PRODUCT PORTFOLIO 298
15.4.4 RECENT DEVELOPMENTS 301
15.5 QIAGEN 302
15.5.1 COMPANY SNAPSHOT 302
15.5.2 REVENUE ANALYSIS 302
15.5.3 PRODUCT PORTFOLIO 303
15.5.4 RECENT DEVELOPMENTS 308
?
15.6 ABBOTT 309
15.6.1 COMPANY SNAPSHOT 309
15.6.2 REVENUE ANALYSIS 309
15.6.3 PRODUCT PORTFOLIO 310
15.6.4 RECENT DEVELOPMENTS/NEWS 310
15.7 BD VERITOR (BD) 312
15.7.1 COMPANY SNAPSHOT 312
15.7.2 REVENUE ANALYSIS 312
15.7.3 PRODUCT PORTFOLIO 313
15.7.4 RECENT DEVELOPMENTS 314
15.8 BIOCARTIS 315
15.8.1 COMPANY SNAPSHOT 315
15.8.2 PRODUCT PORTFOLIO 315
15.8.3 RECENT DEVELOPMENT 315
15.9 BIO-RAD LABORATORIES, INC. 316
15.9.1 COMPANY SNAPSHOT 316
15.9.2 REVENUE ANALYSIS 317
15.9.3 PRODUCT PORTFOLIO 317
15.9.4 RECENT DEVELOPMENT 318
15.10 BOSCH HEALTHCARE SOLUTIONS GMBH 319
15.10.1 COMPANY SNAPSHOT 319
15.10.2 PRODUCT PORTFOLIO 319
15.10.3 RECENT DEVELOPMENT 328
15.11 DANAHER CORPORATION 329
15.11.1 COMPANY SNAPSHOT 329
15.11.2 REVENUE ANALYSIS 329
15.11.3 PRODUCT PORTFOLIO 330
15.11.4 RECENT DEVELOPMENT 330
15.12 HOLOGIC, INC. 331
15.12.1 COMPANY SNAPSHOT 331
15.12.2 REVENUE ANALYSIS 331
15.12.3 PRODUCT PORTFOLIO 332
15.12.4 RECENT DEVELOPMENTS/NEWS 333
15.13 PATHOFINDER 334
15.13.1 COMPANY SNAPSHOT 334
15.13.2 PRODUCT PORTFOLIO 334
15.13.3 RECENT DEVELOPMENT 334
?
15.14 QUIDELORTHO CORPORATION 335
15.14.1 COMPANY SNAPSHOT 335
15.14.2 REVENUE ANALYSIS 335
15.14.3 PRODUCT PORTFOLIO 336
15.14.4 RECENT DEVELOPMENTS/NEWS 337
15.15 SEEGENE INC. 339
15.15.1 COMPANY SNAPSHOT 339
15.15.2 PRODUCT PORTFOLIO 339
15.15.3 RECENT DEVELOPMENTS 343
16 QUESTIONNAIRE 344
17 RELATED REPORTS 348
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security